Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04027231Completed

Electrochemical Behavior of Biomedical Alloys Exposed to Human Synovial Fluid

Role: lead

NCT03848520Completed

Survey of Running Following a TKA

Role: lead

NCT03636971Phase 2Completed

Gait Analysis Following Knee Viscosupplementation

Role: lead

NCT02114489Phase 3Terminated

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis

Role: lead

All 4 trials loaded